Volume of hepatoid component and intratumor M2 macrophages predict prognosis in patients with hepatoid adenocarcinoma of the stomach
The HCR and CD163 + TAMs may be useful prognostic predictors, and TAMs may be novel therapeutic targets of HAS.
Authors
- Shinichiro Kawatoko (ORCID: https://orcid.org/0000-0001-5811-4834)
- Kenichi Kohashi (ORCID: https://orcid.org/0000-0002-2358-7452)
- Yoshinao Oda (ORCID: https://orcid.org/0000-0001-9636-1182)
- Daisuke Kiyozawa (ORCID: https://orcid.org/0000-0002-3761-8491)
- Yoshiaki Taniguchi (ORCID: https://orcid.org/0000-0001-6235-2333)
- Takehiro Torisu (ORCID: https://orcid.org/0000-0001-8256-2549)
- Takanari Kitazono
- Masafumi Nakamura (ORCID: https://orcid.org/0000-0002-5584-8311)
- Takeo Yamamoto
- Tomoharu Yoshizumi
Institutions
- Kyushu University (JP)
- Osaka Metropolitan University (JP)
- Tokyo Metropolitan University (JP)
Publication Details
- Journal
- Gastric Cancer
- Published
- 2024-11-03
- DOI
- https://doi.org/10.1007/s10120-024-01562-x
- Citations
- 3
- Primary Topic
- Testicular diseases and treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.72